Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;506(1):202-205.
doi: 10.1134/S160767292205012X. Epub 2022 Oct 27.

Geldanamycin Enhances the Radioprotective Effect of Peroxyredoxin 6 in Irradiated 3T3 Fibroblasts

Affiliations

Geldanamycin Enhances the Radioprotective Effect of Peroxyredoxin 6 in Irradiated 3T3 Fibroblasts

E G Novoselova et al. Dokl Biochem Biophys. 2022 Oct.

Abstract

The aim of the study was to evaluate the possibility of increasing the radioprotective potential of peroxiredoxin 6 (Prdx6) and its mutant form S32A by their combined use with geldanamycin (GA) for 3T3 fibroblasts irradiated with X-rays at a dose of 6 Gy. The mutant enzyme S32A, which does not have phospholipase activity, exhibits a more pronounced radioprotective activity when combined with GA. The use of this combination of radioprotective drugs completely abolishes the peak of NF-κB activity in irradiated 3T3 cells. Another transcription factor, p53, which is an indicator of the level of cell apoptosis and increases upon irradiation, is also reduced by S32A in combination with GA. The low-molecular-weight protein p21, which is a marker of cell senescence and whose production increases upon irradiation, is also normalized when S32A is used in combination with GA. In addition, the use of this combination of radioprotective drugs significantly reduces the stress response of 3T3 cells to X-ray irradiation.

Keywords: 3T3 fibroblasts; X-ray radiation; apoptosis; cellular stress; senescence, peroxiredoxin 6, geldanamycin.

PubMed Disclaimer

References

REFERENCES

    1. McKelvey, K.J., Hudson, A.L., Back, M., et al., Radiation, inflammation, and the immune response in cancer, Mamm. Genome, 2018, vol. 29, pp. 843–865. - DOI - PubMed - PMC
    1. Cadet, J., Douki, T., and Ravanat, J.-L., Oxidatively generated base damage to cellular DNA, Free Radical Biol. Med., 2010, vol. 49, pp. 9–21. - DOI
    1. Novoselova, E.G., Sharapov, M.G., Lunin, S.M., et al., Peroxiredoxin 6 applied after exposure attenuates damaging effects of X-ray radiation in 3T3 mouse fibroblasts, Antioxidants, 2021, vol. 10, no. 12, p. 1951. - DOI - PubMed - PMC
    1. Li, L., Wang, L., You, Q.D., et al., Heat shock protein 90 inhibitors: an update on achievements, challenges, and future directions, J. Med. Chem., 2020, vol. 12, no. 63 (5), pp. 1798–1822.
    1. Stankova, K., Savova, G., Nikolov, V., et al., HSP90 inhibitor geldanamycin as a radiation response modificator in human blood cells, Dose-response, 2015, vol. 13, no. 1.

LinkOut - more resources